Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-08-07, Stock:ABBV, The news for the past five days is as follows:
2019-07-31: NEWS1: Abbvie Inc (ABBV) EVP, Chief Strategy Officer Henry O Gosebruch Bought $2 million of Shares.NEWS2: AbbVie (NYSE:ABBV) Shareholders Have Enjoyed A 29% Share Price Gain.
2019-08-01: NEWS1: Thursday 8/1 Insider Buying Report: ABBV, WTRE.NEWS2: Thursday 8/1 Insider Buying Report: ABBV, WTRE.
2019-08-02: NEWS1: Pharma Stock Roundup: PFE, MRK, LLY Q2 Earnings, Upjohn-MYL Merger.NEWS2: Pharma Stock Roundup: PFE, MRK, LLY Q2 Earnings, Upjohn-MYL Merger.NEWS3: iShares U.S. Healthcare ETF Experiences Big Outflow.NEWS4: iShares U.S. Healthcare ETF Experiences Big Outflow.NEWS5: Pharma Stock Roundup: PFE, MRK, LLY Q2 Earnings, Upjohn-MYL Merger.
2019-08-05: NEWS1: Momenta (MNTA) Q2 Loss Wider Than Expected, Revenues Miss.NEWS2: Momenta (MNTA) Q2 Loss Wider Than Expected, Revenues Miss.NEWS3: ImmunoGen (IMGN) Stock Down Despite Q2 Earnings & Sales Beat.NEWS4: ImmunoGen (IMGN) Stock Down Despite Q2 Earnings & Sales Beat.NEWS5: Momenta (MNTA) Q2 Loss Wider Than Expected, Revenues Miss.NEWS6: ImmunoGen (IMGN) Stock Down Despite Q2 Earnings & Sales Beat.NEWS7: 5 Dividend Aristocrats Where Analysts See Capital Gains.NEWS8: 5 Dividend Aristocrats Where Analysts See Capital Gains.NEWS9: AbbVie Submits New Drug Application to US FDA for Investigational Elagolix for Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Women.NEWS10: Big Pharma Sees Pockets of Recent Insider Buying.
2019-08-06: NEWS1: Allergan Boosts 2019 Guidance While Waiting to be Acquired by AbbVie.NEWS2: Allergan Boosts 2019 Guidance While Waiting to be Acquired by AbbVie.NEWS3: Allergan Boosts 2019 Guidance While Waiting to be Acquired by AbbVie.NEWS4: Allergan beats second-quarter expectations, boosts full-year guidance.NEWS5: Allergan (AGN) Q2 Earnings & Sales Top, '19 Sales View Up.NEWS6: Allergan (AGN) Q2 Earnings & Sales Top, '19 Sales View Up.NEWS7: Despite Historic Market Performance, IMX Remains Relatively Unchanged.NEWS8: Top Research Reports: Chevron, AbbVie, Phillips 66 & More.NEWS9: Allergan (AGN) Q2 Earnings & Sales Top, '19 Sales View Up.NEWS10: Allergan beats profit, raises revenue forecast on Restasis, Juvederm demand.NEWS11: Allergan beats profit, raises revenue forecast on Restasis, Juvederm demand.NEWS12: Allergan Tops Q2 Profit Estimate, Lifts 2019 Revenue Guidance After Abbive Deal.

Answer: Decrease